Effect of crotapotin and heparin on the rat paw oedema induced by different secretory phospholipases A2

Toxicon

Volumn 38, Issue 2, 2000, Pages 199-208

  Landucci, Elen C T ^a   Toyama, Marcos ^a   Marangoni, Sérgio ^a   Oliveira, Benedito ^a   Cirino, Giuseppe ^b   Antunes, Edson ^a   De Nucci, Gilberto ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PHOSPHOLIPASE A2; POLYPEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ISOLATION; HONEYBEE; IN VITRO STUDY; MALE; NONHUMAN; PANCREAS; PAW EDEMA; PRIORITY JOURNAL; RAT; SNAKE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BEE VENOMS; CROTOXIN; EDEMA; HEPARIN; MALE; PHOSPHOLIPASES A; RATS; RATS, WISTAR; SNAKE VENOMS;

APIS MELLIFERA; APOIDEA; BOVINAE; CROTALUS ADAMANTEUS; CROTALUS DURISSUS TERRIFICUS; NAJA; NAJA NAJA NAJA; SERPENTES;

EID: 0033991677     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(99)00143-9     Document Type: Article

References (34)

1. Bingham C.O. 3rd, Murakami M., Fujishima H., Hunt J.E., Austen K.F., Arm J.P. A heparin-sensitive phospholipase A2 and prostaglandin endoperoxide synthase-2 are functionally linked in the delayed phase of prostaglandin D2 generation in mouse bone marrow-derived mast cells. J. Biol. Chem. 271:1996;25936-25944.
2. Blackwell G.J., Flower R.J., Nijkamp F.P., Vane J.R. Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation and inhibition by anti-inflammatory steroids. Br. J. Pharmacol. 62:1978;79-89.
3. Bon C. Synergism of the two subunits of crotoxin. Toxicon. 2:1982;105-109.
4. Bon C., Changeux J., Jeng T., Fraenkel-Conrat H. Postsynaptic effects of crotoxin and of its isolated subunits. Eur. J. Biochem. 99:1979;471-481.
5. Breithaupt H. Neurotoxic and myotoxic effects of Crotalus phospholipase A and its complex with crotapotin. Naunyn-Schmiedeberg's Arch. Pharmacol. 292:1976;271-278.
6. Cho W., Kézdy F.J. Chromogenic substrates and assay of phospholipase A2. Meth. Enzymol. 197:1991;75-79.
7. Choumet V., Saliou B., Fideler L., Chen Y.C., Gubensek F., Bon C., Delot E. Snake-venom phospholipase A2 neurotoxins. Potentiation of a single-chain crotoxin by the chaperon subunit of a two-component neurotoxin. Eur. J. Biochem. 211:1993;57-62.
8. Cirino G., Peers S.H., Flower R.J., Pepinsky R.B. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw oedema test. Proc. Natl. Acad. Sci. USA. 86:1989;3428-3432.
9. Damerau B., Lege L., Oldigs H.D., Vogt W. Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom. Naunyn Schmiedebergs Arch. Pharmac. 287:1975;141-156.
10. Dennis E.A. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269:1994;13057-13060.
11. Dua R., Cho W. Inhibition of human secretory class II phospholipase A2 by heparin. Eur. J. Biochem. 221:1994;481-490.
12. Ellis J.R. Molecular chaperons: the plant connection Science. 250:1990;954-958.
13. Fonteh A.N., Bass D.A., Marshall L.A., Seeds M., Samet J.M., Chilton F.H. Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cell. J. Immunol. 152:1994;5438-5446.
14. Gopalakrishnakone P., Dempster D.W., Hawgood B.J., Elder H Y. Cellular and mithocondrial changes induced in the structure of murine skeletal muscle by crotoxin, a neurotoxic phospholipase A2 complex. Toxicon. 22:1984;85-98.
15. Habermann E., Breithaupt H. The crotoxin complex- an example of biochemical and paharmacological protein complementation. Toxicon. 16:1978;19-30.
16. Hanahan D.N. Boyer. The enzymes. vol 4:1971;71-84 Academic Press, New York.
17. Heinrikson R.L., Krueger E.T., Keim P.S. Amino acid sequence of phospholipase A2-α from the venom of Crotalus adamanteus. A new classification of phospholipase A2 based upon structural determinants. J. Biol. Chem. 252:1977;4913-4977.
18. Hendon R.A., Fraenkel-Conrat H. Biological role of the two components of crotoxin. Proc. Natl. Acad. Sci. USA. 68:1971;1560-1563.
19. Lambeau G., Ancian P., Barhanin J., Lazdunski M. Cloning and expression of a membrane receptor for secretory phospholipase A2. J. Biol. Chem. 269:1994;1575-1578.
20. Landucci E.C.T., Condino-Neto A., Antunes E., Perez A.C., Hyslop S., Corrado A.P., Novello J.C., Marangoni S., Oliveira B., de Nucci G. Crotoxin induces aggregation of human washed platelets. Toxicon. 32:1994;217-226.
21. Landucci E.C.T., Antunes E., Donato J.L., Faro R., Hyslop S., Marangoni S., Oliveira B., Cirino G., de Nucci G. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. Br. J. Pharmacol. 144:1995;578-583.
22. Landucci E.C.T., Pereira M.F., Cintra A.C.O., Giglio J.R., Marangoni S., Oliveira B., Cirino G., Antunes E., De Nucci G. Mast cell degranulation induced by two phospholipase A2 homologues: dissociation between enzymatic and biological activities. Eur. J. Pharmacol. 343:1998;257-263.
23. Lomonte B., Tarkowski A., Bagge U., Harson L.A. Neutralization of the cytosolic and myotoxic activities of phospholipase A2 from Bothrops asper snake venom by glycosaminoglycans of heparin/heparan sulfate family Biochem. Pharmacol. 47:1994;1509-1518.
24. Melo P.A., Homsi-Brandenburgo M.I., Giglio J.R., Suarez-Kurtz G. Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions. Toxicon. 31:1993;285-291.
25. Moreno J.J., Ferrer X., Ortega E., Carganico G. PLA2 induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action. Agents Actions. 36:1992;258-263.
26. Murakami M., Hara N., Kudo I., Inoue K. Triggering of degranulation in mast cells by exogenous type II phospholipase A2. J. Immunol. 151:1993;5675-5684.
27. Murakami M., Kudo I., Suwa Y., Inoue K. Release of 14-kDa group II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Eur. J. Biochem. 209:1992;257-263.
28. Murakami M., Nakatani Y., Hara N., Kudo I., Inoue K. Role of phospholipase A2 in mast cell activation and function. Glaser K.B., Vadas P. Phospholipase A2 in Clinical Inflammation: Molecular Approaches to Pathophysiology. 1995;93-124 CRC Press, New York.
29. Rubsamen K., Breihaupt H., Habermann E. Biochemistry and pharmacology of the crotoxin complex. I. Subfractionation and recombination of the crotoxin complex. Naunyn-Schmiedeberg's Arch. Pharmacol. 270:1971;274-288.
30. Sartipy P., Johansen B., Camejo G., Rosengren B., Bondjers G., Hurt-Camejo E. Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity. J. Biol. Chem. 271:1996;26307-26314.
31. Slotboom A.J., Verheij H.M., Haas G.H. Hawthorne J.N., Ansell G.B. Phospholipids. 1982;359-435 Elsevier, Amsterdam.
32. Verheij H.M., Boffa M.C., Rothen C., Bryckaert M., Verger R., de Haas G.H. Correlation of enzymatic activity and anticoagulant properties of phospholipase A2. Eur.J.Biochem. 112:1980;25-32.
33. Wait M. Hanahan D.J. The Phospholipases. vol. 5:1987;155 Plenum Press, New York.
34. Yang C.C. Structure-function relationship of phospholipase A2 from snake venoms. J. Toxicol. 13:1994;125-177.